Blood test could spot pancreatic cancer before It's visible
NCT ID NCT02471170
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study collects blood samples from people with pancreatic diseases to look for markers that might signal pancreatic cancer. The goal is to see if a blood test could detect the cancer earlier than current methods or help track how the disease changes during treatment. Samples will also be stored in a biobank for future research. Participants include patients being evaluated or treated for pancreatic disease, as well as control patients without pancreatic disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a simple blood test that detects pancreatic cancer earlier or helps doctors monitor the disease during treatment.
What could go wrong
This is an observational study, not a treatment trial. It may not find reliable markers, and any potential test would require much larger studies to confirm.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Coffee After Pancreatic Surgery Trial (NCT04205058)
- NHS7108 for EPI: Phase 2a Trial (NCT07559175)
- Calgary ERCP Registry Study (NCT04259580)
- Patient Experience in Endoscopic Ultrasound – PR NCT05014347
- Multimodal Medical Imaging AI Study | NCT07445152
- Ondansetron to Prevent Pancreatitis After ERCP (NCT06861010)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States